BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34992437)

  • 1. CCNB2, CDC20, AURKA, TOP2A, MELK, NCAPG, KIF20A, UBE2C, PRC1, and ASPM May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
    Yang Z; Wu X; Li J; Zheng Q; Niu J; Li S
    Int J Gen Med; 2021; 14():10185-10194. PubMed ID: 34992437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of molecular target genes and key pathways in hepatocellular carcinoma by bioinformatics analysis.
    Zhou L; Du Y; Kong L; Zhang X; Chen Q
    Onco Targets Ther; 2018; 11():1861-1869. PubMed ID: 29670361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Hepatocellular Carcinoma.
    Su Q; Li W; Zhang X; Wu R; Zheng K; Zhou T; Dong Y; He Y; Wang D; Ran J
    Curr Pharm Biotechnol; 2023; 24(8):1035-1058. PubMed ID: 35762549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioinformatics Analysis of Candidate Genes and Pathways Related to Hepatocellular Carcinoma in China: A Study Based on Public Databases.
    Zhang P; Feng J; Wu X; Chu W; Zhang Y; Li P
    Pathol Oncol Res; 2021; 27():588532. PubMed ID: 34257537
    [No Abstract]   [Full Text] [Related]  

  • 6. [Bioinformatics analysis of core differentially expressed genes in hepatitis B virus-related hepatocellular carcinoma].
    Yu Y; Cheng J; Mei CZ; Dai YZ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2022 Nov; 34(5):507-513. PubMed ID: 36464255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
    Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
    J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of key genes and pathways in hepatocellular carcinoma: A preliminary bioinformatics analysis.
    Wu M; Liu Z; Zhang A; Li N
    Medicine (Baltimore); 2019 Feb; 98(5):e14287. PubMed ID: 30702595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches.
    Chen H; Wu J; Lu L; Hu Z; Li X; Huang L; Zhang X; Chen M; Qin X; Xie L
    Front Genet; 2020; 11():575762. PubMed ID: 33505422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening core genes and cyclin B2 as a potential diagnosis, treatment and prognostic biomarker of hepatocellular carcinoma based on bioinformatics analysis].
    Yang SY; Ren H; Li CF; Tang H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Sep; 28(9):773-783. PubMed ID: 33053978
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying potential prognosis markers in hepatocellular carcinoma
    Hu X; Zhou J; Zhang Y; Zeng Y; Jie G; Wang S; Yang A; Zhang M
    Front Genet; 2022; 13():942454. PubMed ID: 35928445
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening of potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma using bioinformatic analysis.
    Liu J; Ma Z; Liu Y; Wu L; Hou Z; Li W
    Oncol Lett; 2019 Sep; 18(3):2500-2508. PubMed ID: 31452738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of significant biomarkers with poor prognosis in hepatocellular carcinoma via bioinformatics analysis.
    Sun Q; Liu P; Long B; Zhu Y; Liu T
    Medicine (Baltimore); 2020 Aug; 99(32):e21702. PubMed ID: 32769939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Multiple Hub Genes and Pathways in Hepatocellular Carcinoma: A Bioinformatics Analysis.
    Liu J; Han F; Ding J; Liang X; Liu J; Huang D; Zhang C
    Biomed Res Int; 2021; 2021():8849415. PubMed ID: 34337056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening and Functional Prediction of Key Candidate Genes in Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Chen X; Liao L; Li Y; Huang H; Huang Q; Deng S
    Biomed Res Int; 2020; 2020():7653506. PubMed ID: 33102593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential core genes in triple negative breast cancer using bioinformatics analysis.
    Li MX; Jin LT; Wang TJ; Feng YJ; Pan CP; Zhao DM; Shao J
    Onco Targets Ther; 2018; 11():4105-4112. PubMed ID: 30140156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Key Genes and Prognostic Value Analysis in Hepatocellular Carcinoma by Integrated Bioinformatics Analysis.
    Wang M; Wang L; Wu S; Zhou D; Wang X
    Int J Genomics; 2019; 2019():3518378. PubMed ID: 31886163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjoint analysis for hepatic carcinoma with hub genes and multi-slice spiral CT.
    Zhang S; Peng R; Xin R; Shen X; Zheng J
    Medicine (Baltimore); 2020 Nov; 99(45):e23099. PubMed ID: 33157984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.